MP0533-CP101: Study of MP0533 in Patients Acute Myeloid Leukemia or Myelodysplastic Syndrome (clinicaltrials.gov) - Sep 26, 2026 - P1 | N=80 | Completed | Sponsor: Molecular Partners AG | Active, not recruiting ➔ Completed | Phase classification: P1/2 ➔ P1 | N=249 ➔ 80 | Trial completion date: May 2027 ➔ Sep 2026
Enrollment change • First-in-human • Phase classification • Trial completion • Trial completion date • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Myelodysplastic Syndrome • Oncology
|